$2.1B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | RVMD Revolution Medicines Inc | 7.6M | +0.0% | $1.4B | 67.6% |
| 2 | PBLS Parabilis Medicines Inc | 4.7M | — | $128M | 6.1% |
| 3 | RLAY Relay Therapeutics Inc | 6.8M | +22.6% | $127M | 6.0% |
| 4 | TYRA Tyra Biosciences Inc | 3.6M | −12.4% | $114M | 5.4% |
| 5 | ALMS Alumis Inc | 3.5M | +0.0% | $100M | 4.7% |
| 6 | ORIC Oric Pharmaceuticals Inc | 7.2M | +0.0% | $78M | 3.7% |
| 7 | KYMR Kymera Therapeutics Inc | 278,896 | +0.0% | $32M | 1.5% |
| 8 | ZYME Zymeworks Inc | 1.1M | +0.0% | $29M | 1.4% |
| 9 | GLUE Monte Rosa Therapeutics Inc | 761,153 | +150.2% | $18M | 0.9% |
| 10 | ARVN Arvinas Inc | 1.1M | +108.1% | $17M | 0.8% |
| 11 | CTMX Cytomx Therapeutics Inc. | 4.4M | +0.0% | $17M | 0.8% |
| 12 | SLN Silence Therapeutics Plc | 952,400 | +0.0% | $10M | 0.5% |
| 13 | CRVS Corvus Pharmaceuticals Inc | 450,000 | +0.0% | $7M | 0.3% |
| 14 | CNTX Context Therapeutics Inc | 7.4M | +0.0% | $4M | 0.2% |
| 15 | ENGN Engene Therapeutics Inc | 2.3M | — | $4M | 0.2% |